Targeting of the drug directly to the cells, tissues, or organs with no impact on healthy cells is a challenge. In the current era, it's been made possible by therapeutic interventions. The novel drug delivery systems such as nano particulates, liposomes, aquasomes, phytosomes, dendrimers, nano sponges, nano micelles are developed. Nano micelles are developed for ef icient targeting and are currently in trend as therapeutic carriers of waterinsoluble drugs. Micelles are self-assembling Nano-sized colloidal particles with a hydrophobic core and hydrophilic shell. Among the micelle-forming compounds, amphiphilic copolymers, i.e., polymers consisting of hydrophobic block and hydrophilic block, are gaining increasing attention. Polymeric micelles possess high stability both in vitro and in vivo with good biocompatibility. Nano micelles are used widely because of the smaller size range of 10 to 100nm, with greater drug loading capacity. Advantages over other dosage forms include solubilization of poorly soluble drugs, sustained release, protection of drugs from degradation and metabolism. The property discussed includes CMC, size, and aggregation number, and stability. CMC is the minimum polymer concentration required for micelle formation. Aggregation number (N) is the number of polymeric chains required to form micelles, and it ranges between tens to hundreds. Thermodynamic stability is based on size, the optical clarity of solution, viscosity, and surface tension. Kinetic stability accounts for micellar integrity. This review will discuss some recent trends in using micelles as pharmaceutical carriers such as to deliver drugs in conditions such as TB, cancer, ocular complications, etc.
INTRODUCTION
In order to ameliorate the discrete delivery of drugs with low therapeutic index, assorted drug carriers such as liposomes, microparticles, nano-associates, nanoparticle, and drug polymer-consolidates and polymeric micelles have been lourished. Nano micelles were developed for the irst time in 1984 (Bader et al., 1984) . The polymers utilized to construct nano-micelles must be biodegradable. Extensively employed polymers counts poly (lactide), poly (propylene oxide) (PPO), poly (glycolide), poly (lactide-co-glycolide), and poly (ϵcaprolactone) (PCL) among which ubiquitously utilized hydrophilic polymer being Polyethylene glycol (PEG).
Research on nano-micelles is propelling and is a provocative ield of drug delivery for solubilization, stabilization, and delivery of de inite drugs. Polymeric micelles possess attributes such as small size, distinctive nanoscopic architecture, stability, compatibility with the drugs. The attributes of micelles scrutinized include critical micellization concentration (CMC), micellar aggregation number, structure, dimensions, and thermodynamic and kinetic stability. Polymeric micelles af iliate to the set of amphiphilic copolymers, which on clustering form nano-scale (1-200 nm) assemblage. The outer shell modulates in-vivo pharmacokinetic attributes, whilst inner core rehires the drug, conserves stability, and drug delivery pro ile. The distinctiveness of the polymeric micelles is that they can encapsulate hydrophobic drugs in the core while the exterior can be re ined correspondingly (Kwon and Okano, 1996; Cabral and Kataoka, 2014) . They offer advantages such as facile composition, biocompatible, and considerable ef icacy (Gong et al., 2012) , porter for the abjectly-water soluble medication in their hydrophobic core and target speci icity (Mohamed et al., 2014) . Nano micelles are expensive and provide rise to toxicity issues (Amirmahani et al., 2017) .
Requisites for the formulation of Nano micell
Polymers (Vaishya et al., 2014) Table 1 depicts the polymers used in the formulation of nano micelles.
Approaches for the development of nano micelles
By contemplating the physical and chemical attributes of the polymer chain length and monomer features, nano micelles are composed in two ways,
Direct dissolution approach
Employed for hydrophobic block copolymers like block copolymers of poly (butyl acrylate) and poloxamers (Garnier and Laschewsky, 2006) . Figure 1 describes the direct dissolution technique employed in the preparation of nano micelles.
Solvent casting approach
Methodologies include dialysis, o/w emulsion method, solution casting, and freeze-drying.
Dialysis
Principle: Application of high boiling point and the use of water-soluble organic solvents. Dimethylsulfoxide (DMSO) is a solvent of choice. Figure 2 shows the dialysis technique wherein the mixture is charged into a chemical analysis membrane bag for dialysis averse to water for a minimum period of 12hr with successive water substitution at a definite period of time. Evaporation of organic solvent entails the evolution of drug enriched micelles.
Constraints include drug mislaying and weak potency of encapsulation.
Oil in water emulsion methodology
Drug and copolymer are solubilized in oil miscible liquids along with water for entrapment. Vaporization of organic solvent on stirring incites evolution of hydrophobic drug entrapped nano micelle (La et al., 1996) . Figure 3 shows o/w emulsion method involved in preparing nano micelles (Jones and Leroux, 1999) . (Cholkar et al., 2016 (Cholkar et al., , 2015a (Cholkar et al., ,b, 2014 . Figure 4 illustrates the solution casting approach where redispersion of thin-ilm yields nano micelles (Cagel et al., 2017) .
Solution casting approach

Freeze-drying / Lyophilisation approach
Single pace operation of yielding micelles where the therapeutic entity and copolymers are solubilised in tertiary-butanol together with lyophilized to obtain ine ice crystals. Sublimation of these crystals, as shown in Figure 5 , generates freeze-thawed cake, which upon rehydration yields drug-stacked nanomicelles (Leroux, 2003) .
Recent Developments
Ocular Drug Delivery
Nano micelles can be used to deliver drug intraocularly to improve corneal permeability and improve the ocular bioavailability. Table 2 indicates the advancements in the treatment of ocular disorders along with the polymers used.
Cancer
Gene therapy
Gene therapy comprises of nucleic acid -pluronic polyplex complex that exhibits improved stability by encapsulation of gene rather than adaptation chemically, thus defending against serum degradation (Tiwari et al., 2012; Felber et al., 2012) . Mode of action is by clathrin-mediated endocytosis.
Glioma
Glioma is the recurrent and fatal tumour of the brain, and the rate of prognosis is poor (Hervey-Jumper et al., 2015) . Quercetin nanomicelles were used in the treatment of glioma. Mechanism of action is by hindering the expression of the mutant p53 gene (Xavier et al., 2011) and elevating the rate of apoptosis in glioma affected cells (Siegelin et al., 2009) . Quercetin loaded nanomicelles were composed by the solvent-evaporation technique and analyzed by HPLC (Wang et al., 2016) .
Melanoma
Clotrimazole (CLT) loaded nanomicelles are used in the treatment of melanoma and acts on calcium, potassium channel, and apoptosis (Kaur et al., (Pepić et al., 2004) . Poloxamine (tetronic T1107)
Alpha tocopheroldrug 30.5-39.5nm
Nano micelles remained irm for days under 3-4°C (Ribeiro et al., 2013) . Poloxamine (tetronic T908, T1107, t1307)
Ethoxzolamide
Several faceted dispensation Tuneable medicinal substance delivery pro ile attained by variegated nano micelle organization (Ribeiro et al., 2012) . m-Polyethyleneglycol+ hex poly(lactic acid) Cyclosporine A 53±2nm Improved penetrability across cornea (Tommaso et al., 2011 (Tommaso et al., , 2010 (Tommaso et al., , 2012a Intraocular drug extent in lated in rabbit scrutinization -in vitro biocompatibility review on topical introduction (Tu et al., 2007) . Pluronic F127 with chitosan Dexamethasone 25.4 -28.9nm Remarkable pharmacological reciprocation on instillation (Pepić et al., 2010) . 
Rifampicin
Block copolymer of polyethylene oxide complexed withdistearoyl phosphatidylethanolamine Effectiveness of encapsulation was 83.5 -103.9% 
Increased tumour vaccination by in situ nano micelle -provoking microneedles
Resiquimod (R848) nano micelles are proven to increase the tumour vaccination in situ. Resiquimod is an imidazoquinoline derivative that falls under the category of an immunomodulator. Resiquimod exhibits speci icity for a person's toll-like receptor 7 and 8 conveyed on dendritic cells, macrophages, NK cells, and B-lymphocytes (Kim et al., 2018) .
Atherosclerosis
Iron oxide super paramagnetic Nano micelles, a denovo magnetic probe, is the method of treatment employed.
Principle:
Magnetic resonance imaging (MRI) (Groult et al., 2014) The Nano probes act by passive accumulation in the process of engulfment by the macrophages (Weissleder et al., 2014) .
Criteria for targeting atherosclerotic plaques, 1. PC-stabilised Nano micelle protein corona of ApoB-100, a protein responsible for plaque development (Shapiro and Fazio, 2017) 
A greater degree of PC-PLC expression in atherosclerotic lesions
3. De-esteri ication amidst PC glycerol and phosphate moieties, which are mediated by natural PC-PLC (Exton, 1994) , 89Zr, a radioelement, helps in the detection of the amount of Nano micelles in target tissues (Lechuga-Vieco et al., 2018) .
Nano micelle-in-nano ibre system providing long term dual controlled release in antibacterial medical dressings
Wound healing is a tidy clinical condition in which tissues respond to injury and self heals and can be disserted into 3 phases, as shown in Figure 6 (Lechuga-Vieco et al., 2018; Fumakia and Ho, 2016; Ghavaminejad et al., 2015) .
Pluronic F127 micellar solution was prepared by the ilm dispersion hydration technique. AMX 40mg and pluronic F127 200mg were weighed and dissolved in 30ml methanol contained in 100ml lask, which was stirred up to 4hrs until a homogenous solution was formed. Eliminate excess organic solvent using a rotary evaporator maintained at15rpm, 60°C to form a thin ilm. Reconstitute the ilm by 10ml deionized water and stir at 100rpm for 1.5hr and perform membrane iltration. Transfer this micellar solution to 5ml vials containing 2%w/w mannitol (lyoprotectant) and subject for freeze-drying. The next step is coaxial electrospinning maintained at 16kv voltage, 25±3°C, and 55±5% RH in order to enclose drug-carrying nano micelles in Nano ibres. Collect the ibres and vacuum dry for 24 hours.
Evaluation of nano micelle-in-nano ibre system, 1. ANOVA is employed for statistical analysis.
Encapsulation ef iciency
3. Percentage of drug loading capacity 4. Antibacterial test (Yu et al., 2019) 
Osteoporosis
Osteoporosis is a bone disorder characterized by diminished bone formation, thus condensing the period of survival of bone cells (Riggs and Hartmann, 2003; Riggs et al., 2002) . This is caused by estrogenic de iciency. Raloxifene HCl (RH) nano micelles can be used to treat osteoporosis. The nano micelles were prepared using the Ipegal and condensed form of poly oxythylenee. Nonyl-phenyl ether (C95H184O41) was used as a non-ionic, nondenaturing surfactant with HLB 17, relative mass 1981.99. Raloxifene HCl is a selective oestrogenreceptor modulator (SERM) -non-steroidal agonist (Hochner-Celnikier, 1999; Lewis and Jordan, 2005) .
Tuberculosis
Tuberculosis is an infectious disease affecting the lungs. It is caused by Mycobacterium tuberculosis. The symptoms of TB may include weight loss, loss of apetite, coughing up blood or mucus, fatigue, fever, and night sweats. Nanomicelles of Rifampicin plays an important role in the treatment of tuberculosis. Table 3 shows the research work in Rifampicin nano micelles been made in the treatment of tuberculosis.
Anti-fungal activity
Amphoterecin B nanomicelles were prepared using polyethyleneoxide-b-p [6-HHA] and Polyethylene-bp [HASA] . Analysed by chromatographic technique -HPLC (Adams et al., 2003) .
Antibiotics
Nanomicelles of Thiamphenicol (TAP) and its luorinated derivative, lorfenicol (FF), are employed in veterinary practice (Tao et al., 2014) . Polymers used was Chitosan-stearic acid (CS-SA), which serves as a carrier for the delivery of antibiotics.
CONCLUSIONS
Nanotechnology, a sophisticated area of great value and perspective, deals with the control, manipulation, synthesis, and biofunctionalization of structures/devices at the nanometre scale. Several pharmaceutical applications of Nano micelles are based on their speci ic physicochemical and biological properties regarding size (diameter), surface (porosity), pH, solubility, complexation (binding/ ligand capacity), bioavailability, toxicity, and cellular and molecular effects. Polymers play an important role in designing of nano micelles due to their widespread availability, renewability, low cost, versatility, biocompatibility, biodegradability, and lack of toxicity. Direct dissolution and solvent casting (freeze-drying, solution casting, and emulsi ication) are the main mechanisms applicable for the preparation of Nano micelles. In recent decades, interdisciplinary researches and instantaneous development of nanotechnology for diagnosis (imaging), drug delivery, and targeting of extremely serious disorders, such as cancer, Parkinson and Alzheimer diseases, chronic in lammations, ocular dysfunctions, and microbial/viral infections.
Current research is also focused on developing modern Nanosystems, including noisome, polymeric nanoparticles, Nanocomposite (colloidal) hydrogels, polymeric micelles, dendrimers, aptamers, capsosomes, Nano needles, molecularly imprinted polymers, stimuli-responsive polymers, therapeutic polymers (polymer-drug conjugates), and polymeric, arti icial cells.
